baber/WOPTO huggingface dataset:
Patent DK-0765955-T3 (DK)
Inventor: BRABANT MARC
IPC: D01G15/48
Filed: 1996-09-25
Granted: 1998-11-16
Abstract: The oscillating mechanism, especially a textile machine doffing blade, has an oscillating unit (1) on a shaft (2). The stator of the monophase induction motor (3) is fed with an alternating signal (7), where the frequency is controlled within the range of the required mechanical oscillation frequencies.
Patent DK-0846686-T3 (DK)
Inventor: BANKS BERNARD JOSEPH
IPC: A61K31/4433
Filed: 1997-11-17
Granted: 2002-03-25
Abstract: Compounds of formula (I), <CHEM>  wherein   R<1> is H, C1-6 alkyl optionally substituted by one or more halogen atoms, halogen, CN, C1-6 alkoxycarbonyl optionally substituted by one or more halogen atoms, NO2, CHO, CONH2, CSNH2 or C1-6 alkanoyl optionally substituted by one or more halogen atoms; Ar is a ring "A" where "A" is a phenyl group, or "A" is a 5- or 6-membered heteroaryl group, or Ar is a fused bicyclic moiety "AB" where the "A" ring is as defined above and the "B" ring fused thereto in "AB" is a 5- or 6-membered saturated or partially or fully unsaturated carbocycle, or saturated or partially or fully unsaturated heterocycle R<2> is H, halogen, C1-6 alkyl optionally substituted by one or more halogen atoms, C2-6 alkenyloptionally substituted by one or more halogen atoms, C2-6 alkynyl optionally substituted by one or more halogen atoms, NH2,NH(C1-6 alkanoyl optionally substituted by one or more halogen atoms), NH(C1-6 alkoxycarbonyl optionally substituted by one or more halogen atoms), N(C1-6 alkoxycarbonyl optionally substituted by one or more halogen atoms)2, NH(C1-6 alkyl optionally substituted by one or more halogen atoms), N(C1-6 alkyl optionally substituted by one or more halogen atoms)2, NHCONH(C1-6 alkyl optionally substituted by one or more halogen atoms), N-pyrrolyl, NHCONH(phenyl optionally substituted by one or more halogen atoms),N=CH(phenyl optionally substituted by one or more halogen atoms), OH, C1-6 alkoxy optionally substituted by one or more halogen atoms, SH or S(O)m(C1-6 alkyl optionally substituted by one or more halogen atoms); R<3>, R<4>, R<5>, R<6> and R<7> are each independently H, halogen, nitro, C1-6 alkoxycarbonyl optionally substituted by one or more halogen atoms, C1-6 alkyl optionally substituted by one or more halogen atoms, CN, C1-6 alkanoyl optionally substituted by one or more halogen atoms, CONH2, CSNH2, C1-6 alkoxy optionally substituted by one or more halogen atoms, S(O)m(C1-6 alkyl optionally substituted by one or more halogen atoms) or SF5;   Such compounds and salts have useful parasiticidal qualities.
Patent DK-0890221-T3 (DK)
Inventor: RISBO LARS
IPC: H03F3/217
Filed: 1997-03-26
Granted: 2007-10-08
Abstract: To correct non-linearity and noise in the conversion of a pulse code modulated signal (PCM) into a uniform pulse width modulated signal (UPWM), a model is made of the known non-linearity in the conversion by dividing a plurality of non-linearity components in the model, where the polynomial components are separately weighed with filter coefficients. The model is used as a basis for the construction of a filter of the Hammerstein type whose non-linear parts consist of a division of the PCM signal into a plurality of powers, and whose linear parts are approximated by means of the model made. With the circuit of the invention it is now possible to construct a purely digital amplifier which has a great efficiency, low weight, etc.
Patent DK-0958128-T3 (DK)
Inventor: WOOD JOHN
IPC: B29C53/38
Filed: 1997-07-14
Granted: 2004-07-26
Abstract: Method and apparatus for heat-welding two members by applying radiation, such as infra-red radiation, through one of the members to enter layer(s) interposed between the two members. Method relies on inclusions through thickness of the layer(s) to be responsive to said radiation to raise temperature through thickness and promote bonds at inter-faces with surfaces of said members. The bonds are assessed using thermal imaging camera detecting a near visible radiation arising from the layer(s), which radiation is different from infra-red used for heating.
Patent DK-0915841-T3 (DK)
Inventor: FAESSLER ALEXANDER
IPC: A61K31/495
Filed: 1997-07-16
Granted: 2002-06-10
Abstract: The invention relates to compounds of the formula I,in whichR1 and R2 are, independently of each other, lower alkyl or lower alkoxy-lower alkyl;R3 and R4 are, independently of each other, sec-lower alkyl or tert-lower alkyl;R5 is phenyl or cyclohexyl; andR6 and R7 are, independently of each other, lower alkyl, or, together with the linking nitrogen atom, pyrrolidino, piperidino, 4-lower alkylpiperidino, 1,2,4-triazol-1-yl or 1,2,4-triazol-4-yl;or a salt thereof, provided that at least one salt-forming group is present.These compounds are inhibitors of HIV protease and are therefore suitable, for example, for treating AIDS or its preliminary stages.
Patent DK-0904846-T3 (DK)
Inventor: RAU ARTHUR DIPL-ING FH
IPC: B05B15/652
Filed: 1998-09-28
Granted: 2005-11-07
Abstract: The spray tube (16) is turnably fastened to a housing (5), and the securing device prevents turning of the tube through more than 360 degrees during operation. A locking device (18-23) for the tube permits its angle-indexable turning. The device is actuated manually, hydraulically, or by spring force. There are one or more stops to limit the turning angle for the spray tube.
Patent DK-1049499-T3 (DK)
Inventor: SANDBERG BENGT E B
IPC: A61M1/34
Filed: 1999-01-14
Granted: 2004-02-16
Abstract: An apparatus for use in connection with removal of elements, especially exogenous antibodies, from blood or plasma flowing in an extracorporeal blood circulation system of a patient, where said apparatus comprises a container (1). This container is adapted to receive an adsorbent and comprises an inlet (15) and an outlet (16) which are adapted to be connected to an inlet conduit (19) and an outlet conduit (20), respectively, forming part of the blood circulation system. The container (1) comprises an inlet chamber (31), an adsorption chamber (32) adapted to receive the adsorbent, and an outlet chamber (33). These chambers are arranged in sequence when seen in the flow direction of the blood or the plasma through the container (1) and are separated by means of filter units (11, 12) allowing passage of the blood or the plasma. The inlet (15) and the outlet (16) are arranged adjacent one another in connection with a common movable valve means (21). The valve means is adapted so as in a first position to connect the inlet (15) and the outlet (16) directly with their respective passages (28, 29) in the container wall (4) and so as in a second position to connect said inlet (15) and said outlet (16) with their respective ends of a bypass-forming channel (34) in the container wall (4). The passage (28) associated with the inlet communicates with a transfer channel (30) ending in the inlet chamber (31), whereas the passage (29) associated with the outlet (16) is open into the outlet chamber (33).
Patent DK-0991547-T3 (DK)
Inventor: KEMPEN LAMBERTUS
IPC: B60R9/06
Filed: 1999-04-22
Granted: 2003-06-30
Abstract: A carrying construction to be mounted on the back of a vehicle is provided with a supporting member and carriers which, relative to the supporting member, can be swung upwards into the rest position and downwards into the working position. The supporting member can be placed on a ball head of a drawhook behind the vehicle and can be fixed thereon with the aid of clamping means forming part of the carrying construction, of which the clamping action, after the supporting member has been placed on the ball head, is realized by swinging the carriers downwards.
Patent DK-1097922-T3 (DK)
Inventor: MARUYAMA TORU
IPC: A61K31/557
Filed: 1999-07-14
Granted: 2005-05-30
Abstract: 5-Thia- omega -substituted phenyl-prostaglandin E derivatives represented by general formula (I) wherein each symbol is as defined in the specification. Because of being capable of bonding strongly to PEG2receptors (in particular, the subtype EP4), the compounds represented by general formula (I) are expected as useful in preventing and/or treating immunologic diseases, asthma, bone dysplasia, nerve cell death, lung failure, hepatopathy, acute hepatitis, nephritis, renal insufficiency, hypertension, myocardial ischemia, systemic inflammatory syndrome, ambustion pain, sepsis, hemophagous syndrome, macrophage activation syndrome, Still disease, Kawasaki disease, burn, systemic granulomatosis, ulcerative colitis, Crohn's disease, hypercytokinemia at dialysis, multiple organ failure, shock, etc. Moreover, these compounds participate in sleep disorders and platelet aggregation and, therefore, are expected as useful in preventing/treating these diseases. <CHEM>
Patent ES-2232337-T3 (ES)
Inventor: MAIER KLAUS
IPC: H04L69/40
Filed: 2000-02-11
Granted: 2005-06-01
Abstract: A transmitter module (10) sends two data packet with the same content towards a node (4) of the active network and a corresponding node (4) of the passive network. The data packets are re-marked when entering in the transmission path (11) of the transmitter module (10) intact towards the active module (4). Independent claims are included for: (a) an interface for exchanging packets between a node and a transmission path of a transmission network (b) a transmission network
Patent ES-2200743-T3 (ES)
Inventor: WAGNER MICHAEL
IPC: F24C15/34
Filed: 2000-03-17
Granted: 2004-03-16
Abstract: Designed as a thermal insulator with multi-layered insulating foil and integrated air chambers (21), a functional part (23) fastens directly on a rear part (5) outside a see-through area in an oven door (3). The functional part and a retaining metal sheet (19) built as a frame together with the rear part border an air chamber.
Patent ES-2276651-T3 (ES)
Inventor: WARDLAW STEPHEN C
IPC: G01N15/05
Filed: 2000-06-21
Granted: 2007-07-01
Abstract: Centrifuged material layer volumes are measured and quantified during centrifugation of the material layers. The material layers are differentially highlighted by means of one or more supravital fluorescent dyes or stains which are admixed with the sample being analyzed. This kinetic quantification procedure is particularly useful in performing differential blood cell and platelet counts. The blood sample is centrifuged while being subjected to an intense filtered strobed light source at two different wavelengths. At least one photometric cell layer compaction measurement is made in conjunction with the light flashes so as to record a degree of cell layer compaction as the sample is being centrifuged. In certain cases, after several successive cell layer compaction readings are derived, a compaction curve is identified and the ultimate degree of cell layer compaction is calculated from the derived compaction curve prior to the achievement of the ultimate degree of cell layer compaction.  <IMAGE>
Patent ES-2176150-T3 (ES)
Title: Procedimiento para la fabricacion de un elemento compuesto altamente resistente a esfuerzos termicos.
Inventor: PLOCHL LAURENZ DIPL ING
IPC: C22C9/00
Filed: 2000-01-31
Granted: 2002-12-01
Abstract: Procedimiento para la fabricación de un elemento compuesto altamente resistente a esfuerzos térmicos mediante ensamblado, constando el elemento compuesto de al menos una pieza de grafito y al menos una pieza metálica de una aleación endurecible de cobre, unida por contacto plano a ella, donde primero se coloca una capa o lámina de Cu o de una aleación de Cu sobre las superficies a ensamblar de la(s) pieza(s) de grafito, a continuación se encierran en una cámara a prueba de vacío las piezas de grafito y metal unidas por contacto plano que se deben ensamblar y seguidamente se unen mediante un proceso HIP a temperaturas por debajo del 70 % de la temperatura de fusión de la pieza metálica y con presiones reducidas ajustadas a la estabilidad mecánica de la pieza de grafito.
Patent ES-2360284-T3 (ES)
Inventor: FATTMAN GEORGE
IPC: A61L15/42
Filed: 2000-03-02
Granted: 2011-06-02
Abstract: The invention is a foamed, pressure sensitive, hydrocolloid adhesive for bonding to the body, and methods for its manufacture. The foamed structure of the adhesive itself improves absorbency, enables transmission of moisture through the adhesive, increases flexibility, and lowers product cost, all of which are key elements in making a product that is effective in adhering to the body.
Patent ES-2206145-T3 (ES)
Title: Preparacion de una composicion acuosa para tratar el cuero.
Inventor: EL A MMA ANTON GEORGES
IPC: C14C11/00
Filed: 2000-10-17
Granted: 2004-05-16
Abstract: Un procedimiento para preparar una composición acuosa para tratar cuero, que comprende añadir una cantidad predeterminada de una composición sólida particulada para tratamiento de cuero a una cantidad predeterminada de diluyente o vehículo acuosos en una vasija de en una curtiduría, comprendiendo dicha composición sólida particulada 0, 1% en peso o más, preferiblemente 0, 5% en peso o más, más preferiblemente 1% en peso o más, en base al peso total de dicha composición particulada, de un material higroscópico particulado; y disolver o dispersar dicha composición sólida particulada en dicho diluyente o vehículo acuoso.
Patent ES-2182764-T3 (ES)
Inventor: FLAMME ROBERT
IPC: B65F3/00
Filed: 2000-05-26
Granted: 2003-03-16
Abstract: The manipulator consists of a gripper (3) for the bin (6), a mechanism for moving it vertically, a tipping mechanism and a moving guide panel (5) set in line with a waste separator (7) inside the bin. The guide panel is pivoted to the ends of the two arms (18) of a fork articulated to the gripper and is itself controlled by the arms as the bin is tipped. The collection vehicle also has a selector with a shutter to determine which of its compartments is opened to receive the waste.
Patent ES-2221616-T3 (ES)
Title: Procedimiento para la produccion de ciclo -(asp-dphe-nmeval- arg-gly).
Inventor: JONCZYK ALFRED
IPC: C07K5/06
Filed: 2000-03-01
Granted: 2005-01-01
Abstract: Procedimiento para la producción del pentapéptido cíclico ciclo-(Arg-Gly-Asp-DPhe-NMeVal) mediante ciclación de un pentapéptido linear, seleccionado del grupo H-Arg(Pbf)-Gly-Asp(OBzl)-DPhe-NMeVal-OH, H-Gly-Asp(OBzl)-DPhe-NMeVal-Arg(Pbf)-OH, H-Asp(OBzl)-DPhe-NMeVal-Arg(Pbf)-Gly-OH, H-DPhe-NMeVal-Arg(Pbf)-Gly-Asp(OBzl)-OH o H-NMeVal-Arg(Pbf)-Gly-Asp(OBzl)-DPhe-OH, disociación subsiguiente de los grupos protectores y, opcionalmente, transformación adicional en sus sales inofensivas fisiológicamente.
Patent ES-2193964-T3 (ES)
Title: Composiciones fungicidas.
Inventor: LEADBITTER NEIL
IPC: A01N37/50
Filed: 2000-05-24
Granted: 2003-11-16
Abstract: Método para combatir enfermedades fitopatógenas en plantas de cultivo, caracterizado porque comprende aplicar, a las plantas de cultivo o al hábitat de las mismas que presentan infestación por dicha enfermedad fitopatógena, una cantidad eficaz de una combinación de: a) éster metílico de ácido (E, E)-cx-(metoxiimino)-2-[[[[1-[3-(trifluormetil)fenil]etiliden]amino]oxi]metil]bencenoacético de fórmula I en asociación con b) una benzofenona de fórmula II en donde R1 es hidrógeno, halógeno, alcoxi C1-4 o NO2; y R2 es alquilo C1-6 o bencilo opcionalmente sustituido.
Patent ES-2253235-T3 (ES)
Title: Composiciones cosmeticas y farmaceuticas que comprenden derivados del acido urocanico como secuestradores de radicales o antioxidantes.
Inventor: KAMMEIJER ARTHUR
IPC: A61P37/02
Filed: 2000-06-23
Granted: 2006-06-01
Abstract: Una composición farmacéutica que comprende ácido urocánico y uno de sus productos de oxidación. La invención proporciona el uso del ácido urocánico y uno de sus productos de oxidación para la preparación de una composición farmacéutica o cosmética, por ejemplo para el tratamiento del estrés oxidativo, tal como se manifiesta, por ejemplo, en arrugas y otros signos del envejecimiento tisular, en particular de la piel. El estrés oxidativo en organismos vivos y sus tejidos, en particular la oxidación de proteínas, se ha relacionado con el fenómeno del envejecimiento, formación de arrugas, daño agudo de proteínas, isquemia-reperfusión, ateroesclerosis, y muchas enfermedades crónicas, tales como psoriasis, escleroderma, lupus eritematoso, dermatitis alérgica por contacto, vitiligo, liquen plano y enfermedad de injerto frente a hospedador, y para cuyo tratamiento la invención proporciona ahora una composición farmacéutica o cosmética que comprende el ácido urocánico o su equivalente funcional. Talcomposición también se usa de manera ventajosa para fines moduladores inmunitarios.
Patent ES-2233425-T3 (ES)
Inventor: KOBAYASHI MAKOTO
IPC: C07K5/097
Filed: 2000-08-25
Granted: 2005-06-16
Abstract: A method for producing a compound represented by the general formula (I-A) or the general formula (I-B), comprising the following step: <CHEM>   <CHEM> wherein R<1> is an optionally substituted lower alkyl, and the like; R<2> is a lower alkyl or an optionally substituted aralkyl, and the like; R<3> is a lower alkyl, characterized in that a compound represented by the general formula (II-A) or the general formula(II-B) is treated with thionyl chloride.
Patent ES-2207544-T3 (ES)
Inventor: BONGRANI STEFANO
IPC: A61K31/222
Filed: 2000-07-26
Granted: 2004-06-01
Abstract: The use of racemic or optically active compounds represented by formula (I) and the salts thereof wherein R is H or CH<SUB>3 </SUB>for the preparation of pharmaceutical compositions for the therapy of ophthalmic disorders.
Patent ES-2215754-T3 (ES)
Title: Formulaciones pesticidas que contienen un surfactantes de ester fosfato y un lignosulfonato alcoxilado.
Inventor: CHOW VICTOR SHUI-CHIU
IPC: C09K23/50
Filed: 2000-09-18
Granted: 2004-10-16
Abstract: 1. Un sistema surfactante que comprende: a) al menos un éster de fosfato de poliarilfenol etoxilado de fórmula (1): **(fórmula)** en donde R3 y R6 se eligen independientemente del grupo consistente en hidrógeno, sodio, potasio, y **(fórmula)** b) al menos una sal de lignosulfonato etoxilado que tiene un número medio de unidades de óxido de etileno (OE) igual a 1-4.
Patent ES-2228697-T3 (ES)
Inventor: WILTFANG JENS DR
IPC: G01N33/534
Filed: 2001-06-12
Granted: 2005-04-16
Abstract: A monoclonal antibody designated mAb1E8 deposited as DSMZ number ACC2458, is new. <??>An Independent claim is also included for an antibody mAb1E8 radioactively marked.
Patent ES-2277601-T3 (ES)
Title: Valvula de inyeccion de combustible.
Inventor: WATANABE YOSHIMASA
IPC: F02M47/00
Filed: 2001-06-13
Granted: 2007-07-16
Abstract: Una válvula de inyección de combustible (10) que comprende: un alojamiento (101) provisto con un orificio de inyección de combustible (103) en uno de sus extremos; un conducto de combustible a alta presión (123), conectado al orificio de inyección de combustible (103); una aguja de la válvula (105), para abrir y cerrar el orificio de inyección de combustible (103); una cámara de control (109); un conducto de alimentación; un conducto de descarga; una válvula de control.
Patent ES-2218356-T3 (ES)
Inventor: AUTAJON GERARD
IPC: B65D5/50
Filed: 2001-09-07
Granted: 2004-11-16
Abstract: The packaging case is made from a pre-cut blank (30) and erected by folding. The rectangular median panel (45) is connected to the connecting strip (42) by an articulation strip (44) which is folded back against the connecting strip. The connecting strip and the back panel (49) are in the same direction in relation to the median panel and located in the same wedge compartment in order to reinforce one of the two triangular faces of this wedge compartment.
Patent ES-2248262-T3 (ES)
Inventor: WILHELM MICHAEL
IPC: H04M1/02
Filed: 2001-08-20
Granted: 2006-03-16
Abstract: Different screens (3a or 3b), which are at 90 degree orientations to each other, are driven so that the same image or a section thereof is displayed w.r.t. the screen orientation. The orientation may be selected by a key or speech input made by the user. Independent claims are also included for: (a) a screen unit of a telecommunications terminal (b) a telecommunications terminal with the screen unit
Patent ES-2236243-T3 (ES)
Inventor: GRUBB GARY S
IPC: A61K31/56
Filed: 2001-06-05
Granted: 2005-07-16
Abstract: The present invention provides a contraceptive kit which helps to overcome or ameliorate the problem of breakthrough bleeding and spotting associated with lowest dose (15-20 ug EE) estrogen contraceptives.
Patent ES-2245987-T3 (ES)
Inventor: CHEVALLIER YVONICK
IPC: C01B33/193
Filed: 2001-06-06
Granted: 2006-02-01
Abstract: The invention concerns the use, as thickening or texturing agent in toothpaste compositions, of a highly dispersible precipitated silica having a pH of 3.5 to 9, a DOP oil absorption higher than 200 ml/g, a CTAB specific surface area from 70 to 250 m2, a median diameter of at least 20 mum determined by ultrasound-free laser diffraction, a residual anion rate, expressed in sodium sulphate, less than 5 wt. %.
Patent ES-2230354-T3 (ES)
Inventor: STARK CRISTER
IPC: A01B71/04
Filed: 2001-09-03
Granted: 2005-05-01
Abstract: The invention relates to a disc (1'-1<IV>) for agricultural machines (2), comprising a first and a second side (3', 4'), which first side (3') is designed to bear against a flange (6') formed on a hub (5').  The first side (3') of the disc (1'-1<IV>) comprises a recess (15) designed to at least partly accommodate the flange (6') of the hub (5') and to connect the disc (1'-1<IV>) to the hub (5') therein.
Patent ES-2271070-T3 (ES)
Inventor: NELSON MARK L
IPC: C07C/
Filed: 2001-06-29
Granted: 2007-04-16
Abstract: The present invention pertains, at least in part, to novel 9- substituted minocycline compounds. These minocycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Patent ES-2271073-T3 (ES)
Title: Acondicionador de aire provisto de un dispositivo de aporte de oxigeno.
Inventor: CHOI YOUNG HOON
IPC: F24F8/60
Filed: 2001-09-29
Granted: 2007-04-16
Abstract: Un acondicionador de aire que comprende: una unidad exterior (200) que tiene un intercambiador de calor exterior para la realización del intercambio de calor entre un medio intercambiador de calor y el aire del exterior; una unidad interior (100) que tiene un intercambiador de calor interior para la realización del intercambio de calor entre el espacio interior y el medio intercambiador de calor; y un dispositivo de suministro de aire enriquecido con oxígeno que incluye un compresor (310) para el suministro del aire comprimido, un separador de aire enriquecido con oxígeno (320) para la separación del aire comprimido en aire enriquecido con oxígeno y aire enriquecido con nitrógeno; y un tubo de suministro (304) para el suministro del aire enriquecido con oxígeno procedente del separador de aire enriquecido con oxígeno (320) a la unidad interior (100), donde el separador de aire enriquecido con oxígeno (320) incluye: un cuerpo principal (110); una conexión de salida de aire enriquecido con oxígeno (116) que evacúa el aire enriquecido con oxígeno a través del tubo de suministro; una conexión de salida de aire enriquecido con nitrógeno (117) para la evacuación de aire enriquecido con nitrógeno al exterior; caracterizándose el acondicionador de aire porque el separador de aire enriquecido con oxígeno (320) incluye además: membranas separadoras (120) para la separación de aire comprimido, en aire enriquecido con oxígeno y en aire enriquecido con nitrógeno, en el que el interior del cuerpo principal (110) está dividido en un primer espacio (111a) comunicado con la conexión de aire enriquecido con nitrógeno (117) y un segundo espacio (111b) comunicado con la conexión de aire enriquecido con oxígeno (116); una unidad de mantenimiento de la presión (130 ó 130¿) para el mantenimiento de la diferencia de presión entre el primer espacio y el segundo (111a, 111b) por encima de un nivel predeterminado elevando la presión del primer espacio (111a).